Ohara Pharmaceutical
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ohara Pharmaceutical — overview
Assets Under Management
Type
Corporate Investor
Location
Koka-shi, Shiga, Japan
Alternative Asset Classes
PEVC
About
Ohara Pharmaceutical - known decision makers (4)
| Contact Name | Position | Location | Telephone | Asset Class | |
|---|---|---|---|---|---|
| Auditor | Koka, Japan | PE | |||
| Chief Executive Officer | Koka, Japan | PE | |||
| Managing Executive Officer, General Manager, R&D Division, Director of Clinical Development Center | Koka, Japan | PE | |||
| Managing Executive Officer, General Manager, Reliability Assurance Division | Koka, Japan | PE |
Showing 4 of 4 known decision makers Ohara Pharmaceutical
Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers
Request a demo to see more
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.